Objective: To determine whether BCG revaccination at 19 months of age reduces overall child mortality.
Design: Randomised trial, with follow-up to age 5.
Setting: A health project in Bissau, Guinea-Bissau, which maintains a health and demographic surveillance system in an urban area with 90 000 inhabitants.